Coinsurance (Percentage Participation)

Coinsurance, also known as percentage participation, is a cost-sharing mechanism in insurance where the policyholder and the insurance company share the cost of covered losses or expenses in a specified proportion. The policyholder pays a percentage of the total cost, and the insurance company pays the remaining percentage, up to the policy limit.

Some key features of coinsurance include:

  • Percentage participation: Coinsurance is expressed as a percentage, such as 80/20 or 70/30. This indicates the proportion of the cost that the policyholder and the insurance company will pay, respectively.

  • Policy limits: The coinsurance clause may have a specific limit on the amount that the insurance company will pay. If the total cost of the loss or expense exceeds the policy limit, the policyholder may be responsible for the remaining amount.

  • Deductibles: Coinsurance may be subject to a deductible, which is the amount that the policyholder must pay out of pocket before the coinsurance clause is applied.

  • Encourages risk-sharing: Coinsurance is intended to encourage policyholders to share in the risk of losses or expenses, as it reduces the insurance company's exposure to losses and can help to keep premiums lower.

For example, suppose a business owner has a commercial property insurance policy with a coinsurance clause of 80/20. The policy has a limit of $500,000 and a $10,000 deductible. The business owner experiences a fire that causes $600,000 in damage to the property. The business owner would be responsible for paying the $10,000 deductible, and then the coinsurance clause would apply. The business owner would pay 20% of the remaining $590,000, or $118,000, while the insurance company would pay 80%, or $472,000. However, because the total cost of the loss exceeds the policy limit of $500,000, the business owner would also be responsible for the remaining $100,000.

Next Up

Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.
Most U.S. employers now offer paid maternity leave beyond the legal minimum, but coverage varies widely once you look past the basics. According to Mployer Insights' 2026 analysis of more than 50,000 employer benefit plans, 68% of employers provide paid maternity leave on top of short-term disability, typically adding 8 extra weeks, and half now cover 100% of salary during the disability period. Support drops off from there: only 41% of employers offer paid bonding leave for non-birth parents, and advanced family-building benefits remain even less common, with just 28% covering IVF and 11% offering adoption financial assistance. The data suggests that while baseline maternity leave has become standard, more comprehensive family-building support is still the exception rather than the norm.